XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Sales:        
Total sales, net $ 3,826 $ 2,265 $ 10,761 $ 7,031
Product cost of goods sold 1,451 712 4,735 2,194
Gross profit 2,375 1,553 6,026 4,837
Operating expenses:        
Research and development 41 10 108 36
Sales and marketing 1,835 2,061 5,860 5,942
General and administrative 956 1,771 5,049 4,527
Total operating expenses 2,832 3,842 11,017 10,505
Operating loss (457) (2,289) (4,991) (5,668)
Non-cash loss on modification of common stock warrants (1,922) 0 (1,922) 0
Non-cash gain on changes in fair value of warrant liabilities 2,414 0 4,470 0
Non-cash gain on changes in fair value of contingent liability 0 0 219 0
Other (expense) income, net 171 0 178 (2)
Loss before provision for income taxes (136) (2,289) (2,402) (5,666)
Provision for income taxes 0 0 0 0
Net loss and comprehensive loss (136) (2,289) (2,402) (5,666)
Less: Increase to accumulated deficit due to adjustment to Series B Preferred Stock conversion price 5,657 0 5,657 0
Net loss attributable to common stockholders $ (5,793) $ (2,289) $ (8,059) $ (5,666)
Net loss per share (basic and diluted) (in dollars per share) $ (0.10) $ (0.05) $ (0.15) $ (0.13)
Weighted-average shares of common stock used in computing net loss per share (basic and diluted) (in shares) 56,133 44,921 53,007 43,100
Product [Member]        
Sales:        
Total sales, net $ 3,816 $ 2,259 $ 10,743 $ 7,012
Product cost of goods sold 1,451 712 4,735 2,194
Product and Service, Other [Member]        
Sales:        
Total sales, net $ 10 $ 6 $ 18 $ 19